Changing incidence rate of invasive lobular breast carcinoma among older women

Cancer

Volumn 88, Issue 11, 2000, Pages 2561-2569

  Li, Christopher I ^a   Anderson, Benjamin O ^b   Porter, Peggy ^a   Holt, Sarah K ^c   Daling, Janet R ^a   Moe, Roger E ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

And End Results (SEER) program; Breast neoplasms; Ductal carcinoma; Epidemiology; Lobular carcinoma; Surveillance

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SENESCENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; REGISTRIES;

EID: 0034213078     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000601)88:11<2561::AID-CNCR19>3.0.CO;2-X     Document Type: Article

References (42)

1. Ries LA, Miller BA, Hankey BF, Miller BA, Harras A, Edwards BK, editors. SEER Cancer Statistics Review, 1973-1994. Bethesda (MD): National Cancer Institute; 1997 NIH Pub. No. 97-2789.
2. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni JF Jr. Recent cancer trends in the United States. J Natl Cancer Inst 1995;87:175-82.
3. King AE, Schottenfeld D. The "epidemic" of breast cancer in the U.S.-determining the factors. Oncology 1996;10:453-62.
4. Moe RE, Anderson BO, Holt SK, Ellis G. The incidence of invasive lobular carcinoma is increasing among post-menopausal women. Presented at the 1999 American Society of Clinical Oncology Annual Meeting, Atlanta, GA, May 15-18, 1999.
5. Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996;77:113-20.
6. Schnitt S, Connolly J, Recht A, Silver B, Harris J. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 1989;64:448-54.
7. O'Connor IF, Shembekar MV, Shousha S. Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study. J Clin Pathol 1998;51:935-8.
8. Bonnier P, Romain S, Giacalone PL, Laffargue F, Martin PM, Piana L. Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy. Obstet Gynecol 1995;85:11-7.
9. Newcomer LM, Newcomb PA, Daling JR, Yasui Y, Potter JD. Post-menopausal hormone use and risk of breast cancer by histologic type. Presented at the 1999 Society of Epidemiolgic Research Annual Meeting, Baltimore, MD, June 10-12, 1999.
10. Li CI, Weiss NS, Stanford JL, Daling JR. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 2000;88: 2570-7.
11. SEER User File Documentation [computer program]. SEER*Stat for Windows 95/NT. Version 1.1. Bethesda, MD: National Cancer Institute, 1998:8.
12. Young JL Jr., Percy C, Asire AJ, editors. Surveillance, Epidemiology, and End Results: incidence and mortality, 1973-77. Monogr Natl Cancer Inst 1981;57:1-1082.
13. Gloeckler-Ries LA, Hankey BF, Edwards BK, editors. Cancer statistics review 1973-87. Bethesda (MD): National Cancer Institute; 1990 DHHS Pub. No. NIH 90-2789.
14. Frey CM, McMillen MM, Cowan CD, Horm JW, Kessler LG. Representativeness of the Surveillance, Epidemiology, and End Results program data: recent trends in cancer mortality rates. J Natl Cancer Inst 1992;84:872-7.
15. Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the Surveillance, Epidemiology, and End Results Registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol 1997;50:939-45.
16. Frey CM, Feuer EJ, Timmel MJ. Projection of incidence rates to a larger populations using ecologic variables. Stat Med 1994;13:1755-70.
17. Loring L, Dershaw DD. Ductal carcinoma in situ. Crit Rev Diagn Imaging 1997;38:501-33.
18. Cornford EJ, Wilson AR, Athanassiou E, Galea M, Ellis IO, Elston CW, et al. Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis. Br J Radial 1995;68:450-3.
19. Helvie M, Paramagul C, Oberman H, Adler D. Invasive lobular carcinoma: imaging features and clinical detection. Invest Radiol 1993;28:202-7.
20. Krecke K, Gisvold J. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol 1993;161: 957-60.
21. Newstead G, Baute P, Toth H. Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis. Radiology 1992;184:623-7.
22. Fechner R. Histologic variants of infiltrating lobular carcinoma of the breast. Hum Pathol 1975;6:373-8.
23. Martinez V, Azzopardi J. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology 1979:3:467-88.
24. Domagala W, Markiewski M, Kubiak R, Bartkowiak J, Osborn M. Immunohistochemical profile of invasive lobular carcinoma of the breast: predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive. Virchow Arch 1993;423:497-502.
25. Yeatman T, Cantor A, Smith T, Smith SK, Reintgen DS, Miller MS, et al. Tumor biology of infiltrating lobular carcinoma: implications for management. Ann Surg 1995;222:549-59.
26. Kennedy DL, Baum C, Forbes MB. Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol 1985;65:441-6.
27. Hemminki E, Kennedy DL, Baum C, McKinlay SM. Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86. Am J Public Health 1988;78:1478-81.
28. Wysowski DK, Golden L, Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol 1995;85:6-10.
29. Carr BR. HRT management: the American experience. Eur J Obstet Gynecol Reprod Biol 1996;64S:S17-20.
30. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-45.
31. Frost AR, Terahata S, Yen IY, Siegel RS, Overmoyer B, Silverberg SG. An analysis of prognostic features in infiltrating lobular carcinoma of the breast. Mod Pathol 1995; 8:830-6.
32. Winchester D, Chang H, Graves T, Menck H, Bland K, Winchester D. A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J Am Coll Surg 1998;186:416-22.
33. Dixon J, Anderson T, Page D, Lee D, Duffy S. Infiltrating lobular carcinoma of the breast. Histopathology 1982;6:149-61.
34. Davis RP, Nora PF, Kooy RG, Hines JR. Experience with lobular carcinoma of the breast: emphasis on recent aspects of management. Arch Surg 1979:114:485-8.
35. Silverstein MJ, Lewinsky BS, Waisman JR, Gierson ED, Colburn WJ, Senofsky GM, et al. Infiltrating lobular carcinoma: is it different from infiltrating ductal carcinoma? Cancer 1994;73:1673-7.
36. Martin MA, Welling RE, Strobel SL. Infiltrating lobular carcinoma of the breast treated with segmental and modified radical mastectomy. J Surg Oncol 1989;41:117-20.
37. Fisher E, Fisher B, Sass R, Wickerman L. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer. Cancer 1984;54:3002-11.
38. Du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Robertson JF, et al. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol 1991;17:251-7.
39. Bumpers HL, Hassett JM Jr., Penetrante RB, Hoover EL, Holyoke ED. Endocrine organ metastases in subjects with lobular carcinoma of the breast. Arch Surg 1993;128: 1344-7.
40. Borst M, Ungold J. Metastatic patterns of invasive lobular versus ductal carcinoma of the breast. Surgery 1993;114:637-41.
41. Taal B, den Hartog J, Steinmetz R, Peterse H. The spectrum of gastrointestinal metastases of breast cancer: II. The colon and rectum. Gastrointest Endosc 1992;38:136-41.
42. Harris M, Howell A, Chrissohou M, Swindell R, Hudson M, Sellwood R. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 1984;50:23-30.